Inhibitory mechanism of CMP-LSOPC nanoparticles on advanced glycation end products released during digestion

Advanced glycation end products (AGEs) are harmful molecules formed through non-enzymatic reactions between proteins, lipids, and reducing sugars, contributing to diseases such as diabetes, Alzheimer’s, and cardiovascular conditions. This study investigates the inhibitory mechanisms of CMP-LSOPC nanoparticles (NPs) on AGEs release during gastrointestinal digestion. CMP-LSOPC NPs were synthesized by complexing carboxymethyl pachymaran (CMP) with lotus seedpod oligomeric procyanidins (LSOPC), its structure confirmed via FTIR, UV-Vis, SEM, and DSC analyses. In simulated gastrointestinal conditions, CMP-LSOPC NPs exhibited a significant reduction in AGE formation, achieving up to lowering AGE release by 48.5% compared to LSOPC alone. Furthermore, associated mechanisms are explored, including CMP-LSOPC NPs improving the stability, and antioxidant activity of LSOPC, inhibiting the activity of related hydrolase enzymes in the gastrointestinal environment. The CMP-LSOPC NPs group exhibited 4.1% higher LSOPC content during the gastric phase compared to LSOPC alone, indicating that CMP-LSOPC NPs having better stability. The antioxidant activity, measured through DPPH, ABTS+, and hydroxyl radical scavenging assays, demonstrated that CMP-LSOPC NPs enhanced antioxidant capacity, with a 35% increase in DPPH radical scavenging and 29% increase in ABTS+ radical scavenging compared to LSOPC alone. Enzyme inhibition assays showed a protective effect, with a 22% decrease in trypsin activity and 19% reduction in pepsin activity. Meanwhile, mass spectrometry revealed the presence of more long-chain glycopeptides in the CMP-LSOPC NPs group, which may exert beneficial influence on adiminishing the absorption of harmful AGEs. However, the potential risks of accumulating long glycated peptides in the colon should not be overlooked. Overall, CMP-LSOPC NPs effectively inhibited AGE release, which may offer a promising strategy for reducing dietary AGEs harm.

Authors

Publication Details

Journal
Food Science and Human Wellness
Published
2025-02-01
DOI
https://doi.org/10.26599/fshw.2025.9250481
Primary Topic
Advanced Glycation End Products research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inhibitory mechanism of CMP-LSOPC nanoparticles on advanced glycation end products released during digestion

Ping Wu, Qian Wu, Mengyao Niu, Xiaozhi Ming et al.
Food Science and Human Wellness
Advanced Glycation End Products research
article

Inhibitory mechanism of CMP-LSOPC nanoparticles on advanced glycation end products released during digestion

Ping Wu, Qian Wu, Mengyao Niu, Xiaozhi Ming, Zihao Gong, Wen‐Jun Li, Wei Li, Haiyin Zheng, Cui Cheng, Chenxu Bao
article en

Abstract

Advanced glycation end products (AGEs) are harmful molecules formed through non-enzymatic reactions between proteins, lipids, and reducing sugars, contributing to diseases such as diabetes, Alzheimer’s, and cardiovascular conditions. This study investigates the inhibitory mechanisms of CMP-LSOPC nanoparticles (NPs) on AGEs release during gastrointestinal digestion. CMP-LSOPC NPs were synthesized by complexing carboxymethyl pachymaran (CMP) with lotus seedpod oligomeric procyanidins (LSOPC), its structure confirmed via FTIR, UV-Vis, SEM, and DSC analyses. In simulated gastrointestinal conditions, CMP-LSOPC NPs exhibited a significant reduction in AGE formation, achieving up to lowering AGE release by 48.5% compared to LSOPC alone. Furthermore, associated mechanisms are explored, including CMP-LSOPC NPs improving the stability, and antioxidant activity of LSOPC, inhibiting the activity of related hydrolase enzymes in the gastrointestinal environment. The CMP-LSOPC NPs group exhibited 4.1% higher LSOPC content during the gastric phase compared to LSOPC alone, indicating that CMP-LSOPC NPs having better stability. The antioxidant activity, measured through DPPH, ABTS+, and hydroxyl radical scavenging assays, demonstrated that CMP-LSOPC NPs enhanced antioxidant capacity, with a 35% increase in DPPH radical scavenging and 29% increase in ABTS+ radical scavenging compared to LSOPC alone. Enzyme inhibition assays showed a protective effect, with a 22% decrease in trypsin activity and 19% reduction in pepsin activity. Meanwhile, mass spectrometry revealed the presence of more long-chain glycopeptides in the CMP-LSOPC NPs group, which may exert beneficial influence on adiminishing the absorption of harmful AGEs. However, the potential risks of accumulating long glycated peptides in the colon should not be overlooked. Overall, CMP-LSOPC NPs effectively inhibited AGE release, which may offer a promising strategy for reducing dietary AGEs harm.

Food Science and Human Wellness
Openalex Percentile: Top 96%
Advanced Glycation End Products research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.